Aubrey Wright and Mark Williams | The Columbus Dispatch
NEWARK — The celebration of Ohio’s biggest economic development project in history stretched from Washington, D.C., to Newark on Friday.
Local, state and federal leaders from President Joe Biden to Gov. Mike DeWine welcomed Intel’s $20 billion investment to build two semiconductor plants on land that will be annexed into New Albany from Jersey Township.
Mark Williams | The Columbus Dispatch
Gov. Mike DeWine was enjoying the kind of chaotic Christmas morning at the Governor’s Residence that most parents and grandparents experience. It was 10 a.m. and his children and grandchildren, many of whom had spent the night, were opening presents when DeWine’s counselor, Laurel Dawson, handed the governor a letter.
It was from Intel CEO Pat Gelsinger and Senior Vice President Keyvan Esfarjani, officially telling DeWine that the semiconductor company had picked Greater Columbus for what will be the biggest economic development project in state history.
Mark Williams | The Columbus Dispatch
Intel’s promise to invest $20 billion to build two semiconductor plants in Licking County could be just the start for what the Silicon Valley giant has in mind for Greater Columbus, the company’s CEO told The Dispatch.
The plants, also called fabs, will employ 3,000 workers, and 7,000 construction workers will be needed to build them, Intel said in officially announcing its plans after months-long rumors of a massive economic development project on the horizon.
Mark Williams and Monroe Trembly | The Columbus Dispatch
Intel has picked Greater Columbus for a new factory that figures to spark a new industry for the state.
The Silicon Valley semiconductor maker plans to invest $20 billion in a site in Licking County that will employ 3,000 workers, a source close to the project told The Dispatch.
How quickly such a development could occur depends in part on Congress, which is debating legislation that would provide incentives to bring chip-making back to the U.S.
(New Albany, Ohio) January 10, 2022 – The New Albany Company has appointed its legal counsel Molly Iams as its first General Counsel. In this role, Iams is responsible for overseeing all company legal matters, including developing and negotiating real estate agreements for land sales and acquisitions, development agreements, leases, and real estate covenant and restrictions.
With more than 15 years of experience in real estate transactions, Iams earned her Juris Doctor (J.D.) degree from the William and Mary School of Law and a Bachelor of Arts with distinction from the University of Virginia.
Prior to her appointment, Iams provided legal services to The New Albany Company as both in-house counsel and as an attorney with Underhill & Hodge. She also previously worked as an attorney at MI Homes and as an associate attorney at Vorys, Sater, Seymour and Pease LLP.
“The New Albany International Business Park has experienced unprecedented growth in the last decade, attracting more than $6 billion in private investment to date. Molly’s expertise is critical in our ability to support the growth of new and existing companies in the business park and to continue to be responsive to the companies,” said Bill Ebbing, President and CEO of The New Albany Company. “Momentum remains strong so we are pleased that Molly has joined us as general counsel.”
“It is an honor to represent The New Albany Company and support its commitment to high quality, master-planned development,” said Molly Iams. “New Albany is experiencing unprecedented economic growth, which is a testament to market demand, particularly in the Business Park.”
About The New Albany Company
Established in 1987 as a private partnership, The New Albany Company is the primary developer of New Albany, a nationally recognized strategically-planned community in Central Ohio encompassing more than 17 square miles that features a vibrant town center and cultural district, a country club community and a burgeoning business park. In collaboration with civic leadership, The New Albany Company has spearheaded the growth and development of The New Albany International Business Park, one of the largest and fastest growing business parks in the country and home to several Fortune 100 companies representing more than $6 billion in private investment.
The California-based biotech firm Amgen plans to break ground Friday on a $365-million packaging plant in New Albany.
For the firm’s CEO, Bob Bradway, the move represents a homecoming. Although he is now based in Southern California, Bradway grew up in Upper Arlington and graduated from Columbus Academy in 1981…Continue Reading at The Columbus Dispatch
New Albany’s International Business Park is gaining another speculative industrial building on the northwest corner of Innovation Campus Way and Harrison Road. A joint venture of Tenby Partners and Oakridge Development broke ground on a 130,000-square-foot project at 9360 Innovation Campus Way, Oakridge founder Tyler Ford told Columbus Business First. No tenants have been signed yet. Construction is expected to be completed by December…Continue Reading at Columbus Business First
Biotech firm to invest $365 million, create 400 jobs
Amgen one of the world’s leading biotechnology companies, is expanding its U.S.-based manufacturing footprint with plans to build a new, final product advanced assembly plant in New Albany near Columbus. The new greenfield facility will assemble and package vials and syringes to support the growing demand for Amgen’s medicines. The company plans to invest $365 million and create 400 new jobs upon opening. The site is expected to be operational by 2024…Read more at Ohio Business
Columbus, Ohio – Amgen (NASDAQ:AMGN), one of the world’s leading biotechnology companies, announced today its plans to invest $365 million to build a new manufacturing facility in New Albany, Ohio, creating 400 new jobs upon opening. The facility will feature Amgen’s most advanced assembly and final product packaging capabilities for medicines to be distributed in the U.S. … Read more at Industry Today
The biotechnology company Amgen plans to build a $365 million pharmaceutical factory in New Albany that will employ 400 workers.
The Ohio Tax Credit Authority Monday approved a state tax credit for the project in the New Albany International Business Park, near routes 62 and 161.
Amgen, based in Thousand Oaks, California, plans to start work in the fall on the 270,000-square-foot facility.
In a news release announcing the decision, the company said “the facility will feature Amgen’s most advanced assembly and final product packaging capabilities for medicines to be distributed in the U.S.”…Read the article at Dispatch.com.